International Journal of Oral Science Impact Factor

The raw JIF is strong, but the bigger signal here is the JCI of 3.95. That is very high. It means the journal is performing far above category average after normalization, which matters because oral-science journals can have very different citation cultures.

The smaller annual output matters too. With only 62 citable items in the current JCR row, IJOS is not generating its citation profile by publishing everything respectable. It is generating it by selecting a narrow slice of oral-science work that feels biologically or translationally important.

That is why this number should not be read as a generic prestige badge. It is a signal of editorial selectivity in a specialty lane.

The JCR row above is the authoritative impact factor on this page. For the longer directional view, the table below uses the open Scopus-based impact score series as a trend proxy.

Directionally, the open citation signal is up from 10.47 in 2023 to 12.66 in 2024, though still below the extreme 2021 to 2022 spike. That is the right place to be careful. IJOS is a relatively small, selective journal, and smaller journals can move sharply when a cluster of highly citable papers lands in one citation window.

So the healthy read is not "the journal collapsed after 2021." It is that the journal had an exceptional spike, then settled into a still-very-strong position. The current JCR row and rank show that the normalized level remains elite for the field.

The mistake is to see a top-ranked oral-science journal and assume the journal is appropriate for any good paper related to teeth, craniofacial biology, periodontitis, or oral medicine.

That is usually wrong. IJOS tends to reward work that feels like oral science, not just oral setting:

• mechanism-rich oral biology
• translational studies with genuine biological consequence
• regenerative or developmental oral science
• disease work that says something broader than one clinical cohort

A competent dental paper can still be well below this bar.

In our pre-submission review work on manuscripts targeting IJOS, the recurring problem is not usually formal quality. It is category inflation. The paper is solid and publishable, but the authors are reading "oral science" too broadly and treating a selective journal as if it were simply a better-known dentistry outlet.

Editors usually separate those quickly.

In our pre-submission review work on manuscripts targeting International Journal of Oral Science, four failure patterns recur.

The paper is oral-clinical but not really oral-science. This is common with retrospective dental cohorts or local treatment studies that never rise to a broader biological or translational claim.

Mechanism is too thin for the headline. The manuscript may gesture at pathway or tissue-level meaning, but the data remain mostly descriptive.

The significance is too local. A respectable single-center oral-medicine dataset can still fail if the manuscript does not explain why the result matters beyond one population or one practice context.

The package reads narrow on first pass. IJOS tends to favor manuscripts whose importance is visible early, not papers that need a long discussion section to explain why the findings matter.

If that sounds familiar, an International Journal of Oral Science submission readiness check is usually more useful than another round of styling.

The impact factor does not tell you whether your manuscript feels too narrow, too local, or too clinically descriptive for a journal with this editorial posture. It also does not tell you whether the mechanism is strong enough to justify the significance language in the title and abstract.

That is where good submissions separate from ambitious mismatches. The metric can place the journal. It cannot validate the manuscript.